0 160

Cited 0 times in

SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy

Authors
 Karyn A. Goodman  ;  Rui-hua Xu  ;  Ian Chau  ;  Ming Huang Chen  ;  Byoung Chul Cho  ;  Manish A. Shah  ;  Kei Muro  ;  Yifan Wang  ;  Mari Ichimaru  ;  Qingyuan Liu  ;  Luhua Wang 
Citation
 JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS374, 2022-02 
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0732-183X 
Issue Date
2022-02
Full Text
https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS374
DOI
10.1200/JCO.2022.40.4_suppl.TPS374
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Byoung Chul(조병철) ORCID logo https://orcid.org/0000-0002-5562-270X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194732
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links